PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: FTSE takes cues from Wall Street 'Santa rally'

Wed, 27th Dec 2023 08:26

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

At 0831 GMT, the FTSE 100 was up 0.5% at 7,736.01.

The positive momentum came after the Dow Jones Industrial Average tacked on 159.36 points overnight on its return from Christmas.

Stephen Innes, managing partner at SPI Asset Management, said US equities were "at or above" an overbought state, although that might not have significant implications if economic data did not warrant a rebuttal.

"Especially as the current market juncture coincides with the onset of the 'Santa rally' window, this officially-designated period spans seven sessions, covering the final five sessions of the year and the first two sessions of the new calendar.

"But really, the unofficial Santa Rally window opened in November when Fed Waller dropped the front-end rates anchor.

"Irrespective of the developments this week and early next, 2023 has already witnessed a Santa rally."

Innes noted that the S&P showed a "remarkable" 16% increase from late October lows through Christmas.

"This robust market performance during the specified period underscores the presence of a Santa rally, leaving little room for doubt.

"Aside from the customary Santa seasonality, any gains witnessed for the remainder of this week may be attributed to the notable increase in the probability of a soft landing, as indicated by the latest round of high-impact macroeconomic data from the United States."

Boxing day footfall shows some improvement, China industrial profits rise

In a very quiet day for economic news, fresh retail data showed Boxing Day foot traffic saw a slight uptick, with a 1.4% increase in the number of shoppers compared to the last year.

However, when compared to 2019 before the onset of the Covid-19 pandemic and lockdowns, footfall on Boxing Day was still down by about 30%, according to the data from MRI Software, formerly known as Springboard.

Elsewhere, China's industrial profits saw substantial growth in November, marking a double-digit increase of 29.5%, following a 2.7% rise in October.

The surge in profits was underpinned by an overall improvement in manufacturing and a notable upturn in industrial output during the same month.

However, some sectors of the Chinese economy failed to meet expectations due to persistently weak demand.

Despite the positive momentum in November, data from the National Bureau of Statistics (NBS) in Beijing showed that industrial earnings in the first 11 months of 2023 still showed a year-on-year contraction of 4.4%.

This decline, though significant, was still an improvement from the 7.8% drop reported from January to October.

Anglo American up on reports of partial Woodsmith sale

On London's equity markets, Anglo American was among the top risers amid reports that it was preparing to sell a minority stake in Britain's biggest mining project.

According to the Times, the mining giant was looking to share the cost of the $9bn Woodsmith fertiliser mine in North Yorkshire, with chief executive Duncan Wanblad reportedly telling City analysts it was moving "at pace to find a partner".

Elsewhere, AstraZeneca was in the green after it said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

AstraZeneca said it would acquire all of Gracell's shares at $2 per share in cash, plus a non-tradable contingent value right of 30 cents per ordinary share payable upon achievement of a specified regulatory milestone.

The upfront cash portion represented a 62% premium to Gracell's closing market price on 22 December.

HgCapital Trust was also moving higher after it announced a partial sale of IRIS Software Group (IRIS) to LGP, a private equity firm based in Los Angeles.

The terms of the transaction were not disclosed, but the transaction valued its investment in IRIS at £99.8m.

HGT said it would receive a net distribution of £42.1m after reinvesting a portion of its proceeds in the business alongside other institutional clients of Hg investing through Hg Saturn.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,738.71 0.00%

FTSE 250 (MCX) 19,681.20 0.00%

techMARK (TASX) 4,308.32 0.00%

FTSE 100 - Risers

Ocado Group (OCDO) 751.20p 3.61%

Anglo American (AAL) 1,993.40p 3.19%

Rentokil Initial (RTO) 444.20p 2.52%

Intertek Group (ITRK) 4,270.00p 1.96%

Entain (ENT) 998.60p 1.90%

Endeavour Mining (EDV) 1,819.00p 1.85%

Scottish Mortgage Inv Trust (SMT) 800.40p 1.83%

Glencore (GLEN) 474.45p 1.74%

Spirax-Sarco Engineering (SPX) 10,520.00p 1.50%

Ashtead Group (AHT) 5,452.00p 1.45%

FTSE 100 - Fallers

Pearson (PSON) 952.00p -1.20%

Vodafone Group (VOD) 68.57p -0.85%

Smurfit Kappa Group (CDI) (SKG) 3,162.00p -0.75%

BT Group (BT.A) 126.35p -0.75%

Imperial Brands (IMB) 1,808.50p -0.58%

Coca-Cola HBC AG (CDI) (CCH) 2,279.00p -0.44%

Centrica (CNA) 141.30p -0.42%

Next (NXT) 8,182.00p -0.34%

Haleon (HLN) 320.45p -0.33%

Melrose Industries (MRO) 565.40p -0.21%

FTSE 250 - Risers

PureTech Health (PRTC) 192.40p 5.48%

Diversified Energy Company (DEC) 1,130.50p 3.34%

Darktrace (DARK) 362.50p 3.13%

Bellevue Healthcare Trust (Red) (BBH) 153.00p 2.96%

AO World (AO.) 99.95p 2.62%

HGCapital Trust (HGT) 436.50p 2.22%

BBGI Global Infrastructure S.A. NPV (DI) (BBGI) 143.40p 2.14%

Investec (INVP) 543.40p 2.10%

Future (FUTR) 761.00p 2.08%

Bytes Technology Group (BYIT) 617.50p 2.07%

FTSE 250 - Fallers

Carnival (CCL) 1,306.50p -4.39%

SDCL Energy Efficiency Income Trust (SEIT) 63.40p -3.35%

Trustpilot Group (TRST) 145.30p -2.15%

Jupiter Fund Management (JUP) 89.85p -2.07%

Mitchells & Butlers (MAB) 255.00p -1.92%

TI Fluid Systems (TIFS) 150.60p -1.70%

Empiric Student Property (ESP) 93.00p -1.59%

Domino's Pizza Group (DOM) 378.00p -1.56%

Caledonia Investments (CLDN) 3,495.00p -1.55%

Sirius Real Estate Ltd. (SRE) 92.60p -1.49%

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.